WHO MONICA Project: assessing CHD mortality and morbidity

J Tuomilehto1, K Kuulasmaa

  • 1Department of Epidemiology, National Public Health Institute, Helsinki, Finland.

Insights

The WHO MONICA Project monitors acute myocardial infarction (heart attack) mortality and morbidity across 26 countries. While standardizing event registration, variations in diagnostic data limit cross-center comparisons but not within-center trend monitoring.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • The World Health Organization (WHO) MONICA Project aims to monitor trends in acute myocardial infarction (AMI).
  • Standardized procedures for AMI event registration were implemented across multiple international collaborating centers.
  • Routine mortality statistics and event registration data are utilized for analysis.

Purpose of the Study:

  • To present ischaemic heart disease mortality figures based on routine statistics.
  • To discuss the cross-sectional comparability of AMI morbidity data collected through event registration.
  • To evaluate the impact of data availability on diagnostic classification and inter-center comparisons.

Main Methods:

  • Monitoring mortality and morbidity of acute myocardial infarction over a 10-year period.
  • Standardizing myocardial infarction registration procedures and classifying coronary events using common criteria.
  • Analyzing routine statistics for study populations and event registration data.

Main Results:

  • Ischaemic heart disease mortality figures are presented based on routine statistics.
  • Variations exist in the proportions of different diagnostic categories across centers due to differences in data availability (e.g., autopsy data).
  • These variations pose challenges for cross-sectional comparisons of morbidity data between centers.

Conclusions:

  • The primary goal of monitoring morbidity changes within centers over the 10-year period remains achievable.
  • Despite challenges in cross-sectional comparability, the project effectively tracks temporal trends in AMI within individual centers.
  • The findings highlight the importance of consistent data collection for robust international epidemiological studies.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...